Showing results (301-310 of 355) with videos related to

Sort By:
Pageof 36
Cancer Chemotherapy and Pharmacology|April 21, 2009
A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancerYoshitaka Totani, Yuji Saito, Masamichi Hayashi, et al.
Clinical Nephrology|August 28, 2001
Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathyM Nishimura, T Sasaki, A Ohishi, et al.
Annals of Clinical Biochemistry|March 15, 2018
Surveillance evaluation of the standardization of assay values for serum total 25-hydroxyvitamin D concentration in JapanHiroshi Ihara, Sachiko Kiuchi, Takayuki Ishige, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 17, 2022
Molecular and functional characterization of an evolutionarily conserved CREB-binding protein in the Lymnaea CNSDai Hatakeyama, Hiroshi Sunada, Yuki Totani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2008
[A case of advanced small cell lung cancer complicated by chronic renal failure treated with amrubicin]Sumito Isogai, Yoshitaka Totani, Yasuo Kohashi, et al.
International Journal of Hematology|January 31, 2015
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapyHaruhito Totani, Shigeru Kusumoto, Takashi Ishida, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|March 18, 2005
[Clinical characterization of CA19-9 in patients with interstitial pneumonia showing pathological nonspecific interstitial pneumonia pattern]Yoshitaka Totani, Yuji Saito, Hiromi Miyachi, et al.
Nature Communications|November 18, 2022
A Myb enhancer-guided analysis of basophil and mast cell differentiationTakayoshi Matsumura, Haruhito Totani, Yoshitaka Gunji, et al.
Cancer Science|February 16, 2020
Expression, mutation, and methylation of cereblon-pathway genes at pre- and post-lenalidomide treatment in multiple myelomaTakuto Tachita, Shiori Kinoshita, Masaki Ri, et al.
International Journal of Hematology|May 24, 2019
Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myelomaTakashi Yoshida, Masaki Ri, Haruna Fujinami, et al.
Pageof 36